Literature DB >> 18384212

The pathology of pulmonary disorders due to Aspergillus spp.

Richard L Kradin1, Eugene J Mark.   

Abstract

Diagnosing the range of pulmonary disorders caused by Aspergillus spp can be challenging. In instances of hypersensitivity responses to Aspergillus spp (ie, allergic bronchopulmonary aspergillosis, bronchocentric granulomatosis, and hypersensitivity pneumonitis), the surgical pathologist must be cognizant of their relationship to infection, as fungal organisms may be rare or absent from the biopsy specimens. Within the spectrum of opportunistic infection, it is critical to distinguish Aspergillus spp from other fungal mimics, as well as to discern whether infection is limited, progressive, or immanently life threatening. However, the surgical pathologist who establishes expertise in this area will be rewarded by the satisfaction of having contributed primarily to an important area of patient care. This article reviews the spectrum of pulmonary disorders due to infection by Aspergillus spp, with emphasis on the clinical implications of diagnosis.

Entities:  

Mesh:

Year:  2008        PMID: 18384212     DOI: 10.5858/2008-132-606-TPOPDD

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  23 in total

1.  Aspergillus fumigatus Cell Wall Promotes Apical Airway Epithelial Recruitment of Human Neutrophils.

Authors:  Michael B Feldman; Richard A Dutko; Michael A Wood; Rebecca A Ward; Hui Min Leung; Ryan F Snow; Denis J De La Flor; Lael M Yonker; Jennifer L Reedy; Guillermo J Tearney; Hongmei Mou; Bryan P Hurley; Jatin M Vyas
Journal:  Infect Immun       Date:  2020-01-22       Impact factor: 3.441

Review 2.  [Immunodeficiency and immunocompromised patients. Opportunistic infection of the lungs].

Authors:  F Länger; H H Kreipe
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

3.  Crystal structures and small-angle x-ray scattering analysis of UDP-galactopyranose mutase from the pathogenic fungus Aspergillus fumigatus.

Authors:  Richa Dhatwalia; Harkewal Singh; Michelle Oppenheimer; Dale B Karr; Jay C Nix; Pablo Sobrado; John J Tanner
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

Review 4.  Chronic Aspergillosis of the Lungs: Unravelling the Terminology and Radiology.

Authors:  S R Desai; V Hedayati; K Patel; D M Hansell
Journal:  Eur Radiol       Date:  2015-03-20       Impact factor: 5.315

Review 5.  A case series of non-valvular cardiac aspergillosis in critically ill solid organ transplant and non-transplant patients and systematic review.

Authors:  Annalan Md Navaratnam; Mohammad Al-Freah; Anna Cavazza; Georg Auzinger
Journal:  J Intensive Care Soc       Date:  2020-07-06

Review 6.  Asthma and Fungus: Role in Allergic Bronchopulmonary Aspergillosis (ABPA) and Other Conditions.

Authors:  Meenu Singh; Nandini Paul; Shreya Singh; Gyan Ranjan Nayak
Journal:  Indian J Pediatr       Date:  2018-03-17       Impact factor: 1.967

7.  Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis.

Authors:  Ronen Ben-Ami; Nathaniel D Albert; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  J Infect Dis       Date:  2013-01-09       Impact factor: 5.226

8.  Role of germination in murine airway CD8+ T-cell responses to Aspergillus conidia.

Authors:  Steven P Templeton; Amanda D Buskirk; Brandon Law; Brett J Green; Donald H Beezhold
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

Review 9.  Targeting UDP-galactopyranose mutases from eukaryotic human pathogens.

Authors:  Karina Kizjakina; John J Tanner; Pablo Sobrado
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 10.  Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis.

Authors:  Mingxiang Zou; Lanhua Tang; Shushan Zhao; Zijin Zhao; Luyao Chen; Peng Chen; Zebing Huang; Jun Li; Lizhang Chen; Xuegong Fan
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.